A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

Manual for Staging of Cancer

1992 • 2,367 citations

Tests for Linear Trends in Proportions and Frequencies

1955 • 2,021 citations

Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.

1993 • 564 citations

Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition

1989 • 386 citations

Progress in Hemostasis and Thrombosis.

1974 • 349 citations

Different angiogenic pathways characterize superficial and invasive bladder cancer.

1995 • 293 citations

Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer

1995 • 231 citations

Flow Cytometry Versus Urinary Cytology in the Evaluation of Patients with Bladder Cancer

1986 • 126 citations

STUDY OF FIVE HUNDRED PATIENTS WITH ASYMPTOMATIC MICROHEMATURIA

1956 • 107 citations

Detection of Autocrine Motility Factor in Urine as a Marker of Bladder Cancer

1988 • 99 citations

283. Note: On McNemar's Test for the 2 × 2 Table and Its Power Function

1970 • 77 citations

Cancer Detection by Quantitative Fluorescence Image Analysis

1988 • 63 citations

Evaluation of Biological Markers in Bladder Cancer

1975 • 52 citations

The Predictive Value of Flow Cytometry and Urinary Cytology in the Followup of Patients with Transitional Cell Carcinoma of the Bladder

1992 • 42 citations

A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin(ogen) degradation products.

1984 • 34 citations

Further study of fibrinogen degradation products in bladder cancer detection

1978 • 32 citations

Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.

1992 • 32 citations

The structure of the fibrinogen degradation products.

1974 • 23 citations

The Value of Urinary Fibrin/Fibrinogen Degradation Products as Tumor Markers in Urothelial Carcinoma

1984 • 22 citations

Value of DNA Analysis for Treatment of Renal Cell Carcinoma

1990 • 8 citations